Combining genetic, immunological, and clinical investigation, they highlight the surprisingly narrow disease susceptibility of IRF7 deficiency and reveal potential compensatory immunological mechanisms, including IFN-β and adaptive immunity. The gene discussed is IFNB1; the disease is hyperinsulinemic hypoglycemia, familial, 4.